Bivalirudin Anticoagulation for a Patient with Hypercoagulable Immune Syndromes Undergoing Mitral Valve Surgery

Annals of Thoracic Surgery

Volumn 81, Issue 6, 2006, Pages 2308-2310

  Cain, Rebecca L ^a   Spiess, Bruce D ^a   Nelson, Mark ^a   Deanda Jr , Abe ^a   McCarthy, Harry L ^a   Green, Jeffrey A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; HIRULOG;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLEEDING; CARDIOPULMONARY BYPASS; CASE REPORT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART EJECTION FRACTION; HEPARIN INDUCED THROMBOCYTOPENIA; HOSPITAL DISCHARGE; HUMAN; HYPERCOAGULABILITY; MITRAL VALVE; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; THROMBOCYTE COUNT; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ADULT; ANTIBODY SPECIFICITY; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; AUTOANTIBODIES; CROSS REACTIONS; DRUG EVALUATION; DRUG THERAPY, COMBINATION; FEMALE; HEART FAILURE, CONGESTIVE; HEPARIN; HIRUDINS; HUMANS; HYPERTENSION, PULMONARY; KIDNEY FAILURE, CHRONIC; LUPUS ERYTHEMATOSUS, SYSTEMIC; MITRAL VALVE INSUFFICIENCY; PEPTIDE FRAGMENTS; PLATELET COUNT; PLATELET FACTOR 4; RECOMBINANT PROTEINS; RENAL DIALYSIS; THROMBOCYTOPENIA; THROMBOPHILIA; WARFARIN;

EID: 33646839609     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2005.08.033     Document Type: Article

References (8)

1. Warkentin T.E., and Greinacher A. Heparin induced thrombocytopenia and cardiac surgery. Ann Thorac Surg 76 (2003) 638-648
2. Lincoff A.M., Bittl J.A., Harrington R.A., Kleiman N.S., et al., The Replace-2 Investigators. Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention. replace-2 randomized trial. JAMA 289 (2003) 853-863
3. Koster A., Meyer O., Fischer T., et al. One-year experience with the platelet glycoprotein IIb/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II. J Thorac Cardiovasc Surg 122 (2001) 1254-1255
4. Koster A., Chew D., Grundel M., et al. An assessment of different filter systems for extracorporeal elimination of bivalirudin. an in vitro study. Anesth Analg 96 (2003) 1316-1319
5. Koster A., Spiess B.D., Chew D.P., et al. Effectiveness of bivalirudin as a replacement for heparin during cardiopulmonary bypass in patients undergoing coronary artery bypass grafting. Am J Cardiology 93 (2004) 356-359
6. Merry A.F., Raudkivi P.J., Middleton N.G., et al. Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery. Ann Thorac Surg 77 (2004) 925-931
7. Park K.W. The antiphospholipid syndrome. Int Anesthesiol Clin Summer 42 (2004) 45-57
8. Capila I., Hernaiz M.J., Mo Y.D., et al. Annexin V-heparin oligosaccharide complex suggests heparan sulfate-mediated assembly on cell surfaces. Structure 9 (2001) 57-64